/PRNewswire/ HemoShear Therapeutics, Inc., a privately held biotechnology company developing drugs for rare metabolic disorders, has appointed Patrick Horn,.
Former FDA head Stephen Hahn is adding a new title to his role at Flagship Pioneering: CEO of the incubator's blood cancer test startup Harbinger Health. Takeda's oncology leader Rachael Brake heads to Corbus as chief scientific officer charged with redefining scope of early-stage pipeline. Goldfinch Bio snags 13-year Ardelyx vet as CSO.
Latam: el trío de hombres que debe recabar 4 000 mdd de varios interesados reportur.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reportur.com Daily Mail and Mail on Sunday newspapers.
Albireo Pharma, Inc (ALBO) Q4 2020 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.